TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,657 | -69.5% | 437,642 | -9.4% | 0.00% | -75.0% |
| Q2 2023 | $12,001 | +1.0% | 483,082 | -38.9% | 0.01% | +60.0% |
| Q1 2023 | $11,883 | +41.5% | 790,093 | +11.3% | 0.01% | +25.0% |
| Q4 2022 | $8,400 | -99.8% | 710,068 | +19.9% | 0.00% | 0.0% |
| Q3 2022 | $3,505,000 | +150.2% | 592,129 | +79.6% | 0.00% | +300.0% |
| Q2 2022 | $1,401,000 | +5.0% | 329,769 | +135.1% | 0.00% | 0.0% |
| Q1 2022 | $1,334,000 | -83.9% | 140,291 | -67.9% | 0.00% | -50.0% |
| Q4 2021 | $8,300,000 | +148.8% | 436,790 | +335.8% | 0.00% | 0.0% |
| Q3 2021 | $3,336,000 | +249.0% | 100,231 | +306.7% | 0.00% | – |
| Q2 2021 | $956,000 | -83.6% | 24,643 | -79.7% | 0.00% | -100.0% |
| Q1 2021 | $5,847,000 | +83.7% | 121,309 | +98.3% | 0.00% | +50.0% |
| Q4 2020 | $3,183,000 | -75.3% | 61,189 | -87.3% | 0.00% | -75.0% |
| Q3 2020 | $12,898,000 | -28.3% | 482,016 | -47.8% | 0.01% | -42.9% |
| Q2 2020 | $17,998,000 | +112.5% | 923,949 | +7.3% | 0.01% | +100.0% |
| Q1 2020 | $8,471,000 | -3.8% | 860,919 | +8.5% | 0.01% | +40.0% |
| Q4 2019 | $8,807,000 | +867.8% | 793,422 | +389.1% | 0.01% | +400.0% |
| Q3 2019 | $910,000 | +59.9% | 162,212 | +146.7% | 0.00% | – |
| Q2 2019 | $569,000 | +292.4% | 65,763 | +264.5% | 0.00% | – |
| Q1 2019 | $145,000 | -31.0% | 18,041 | -64.8% | 0.00% | – |
| Q4 2018 | $210,000 | +50.0% | 51,258 | +106.0% | 0.00% | – |
| Q3 2018 | $140,000 | +11.1% | 24,881 | +159.6% | 0.00% | – |
| Q2 2018 | $126,000 | -61.9% | 9,583 | -58.9% | 0.00% | – |
| Q1 2018 | $331,000 | +255.9% | 23,304 | +107.1% | 0.00% | – |
| Q4 2017 | $93,000 | -69.7% | 11,251 | -56.6% | 0.00% | – |
| Q3 2017 | $307,000 | -43.5% | 25,921 | -52.1% | 0.00% | -100.0% |
| Q2 2017 | $543,000 | +5933.3% | 54,077 | +6559.7% | 0.00% | – |
| Q1 2017 | $9,000 | -10.0% | 812 | -61.6% | 0.00% | – |
| Q4 2016 | $10,000 | +25.0% | 2,113 | +127.2% | 0.00% | – |
| Q3 2016 | $8,000 | – | 930 | +2168.3% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 41 | -99.7% | 0.00% | – |
| Q1 2016 | $97,000 | +4750.0% | 12,075 | +6571.3% | 0.00% | – |
| Q4 2015 | $2,000 | -88.9% | 181 | -90.0% | 0.00% | – |
| Q3 2015 | $18,000 | -82.5% | 1,814 | -71.7% | 0.00% | – |
| Q2 2015 | $103,000 | +18.4% | 6,420 | +9.4% | 0.00% | – |
| Q1 2015 | $87,000 | -96.8% | 5,866 | -96.8% | 0.00% | -100.0% |
| Q4 2014 | $2,753,000 | +19564.3% | 183,551 | +12369.5% | 0.00% | – |
| Q3 2014 | $14,000 | +250.0% | 1,472 | +263.5% | 0.00% | – |
| Q2 2014 | $4,000 | 0.0% | 405 | -40.6% | 0.00% | – |
| Q1 2014 | $4,000 | +300.0% | 682 | +97.7% | 0.00% | – |
| Q4 2013 | $1,000 | -66.7% | 345 | -40.6% | 0.00% | – |
| Q3 2013 | $3,000 | -25.0% | 581 | -13.3% | 0.00% | – |
| Q2 2013 | $4,000 | – | 670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |